摘要
目的观察前列安联合哈乐治疗良性前列腺增生(BPH)膀胱逼尿肌受损的临床疗效。方法以尿动力学检查逼尿肌收缩力分级为极弱(VW)和弱减(W-)、弱加(W+)的前列腺增生症患者为主要观察对象,按随机数字表法随机分为2组,治疗组(前列安联合盐酸坦索罗辛缓释胶囊)30例,对照组(盐酸坦索罗辛缓释胶囊)30例,4周为1疗程,观察1疗程。结果治疗组总有效率为83.33%;对照组总有效率为63.33%(P<0.05)。治疗组Ⅰ-PSS评分、膀胱剩余尿量平均减少均明显优于对照组(P<0.05)。结论前列安联合盐酸坦索罗辛缓释胶囊治疗BPH膀胱逼尿肌收缩力受损有较好疗效。
Objective Objective： To observe the clinical efficacy of Qianliean combined with the Tamsulosin hydrochloride extended-release capsules on the treatment of benign prostatic hyperplasia（ BPH） detrusorunderactivity. Methods To benign prostatic hyperplasia patients of urodynamics to check the detrusor contractility grading： very weak（ VW） and weak minus（ W-）,weak plus（ W ＋） as the main target of observation. According to the random number table,patients were divided into two？groups,the treatment group with 30 patients in it（ Qianliean combined with the Tamsulosin hydrochloride extended-releasecapsules）,and the control group with 30 cases in it（ Tamsulosin hydrochloride extended-release capsules）,a course of four weeks,observe a course. Results The treatment group efficacy rate was 83. 33%; the control group efficacy rate was 63. 33%（ P 〈 0.05）. I-PSS scor and bladder residual urine volume average of the treatment group were better than the control group（ P 〈 0.05） obviously. Conclusion Qianliean combined with the Tamsulosin hydrochloride extended-release capsules had a good effect for the BPH detrusor impaire dcontractility.
出处
《时珍国医国药》
CAS
CSCD
北大核心
2017年第1期144-146,共3页
Lishizhen Medicine and Materia Medica Research
基金
河南省中医药科学研究专项课题(No.2013ZY01009)
河南省郑州市科技创新团队(No.121PCXTD522)
河南省中医临床学科领军人才培养计划(No.2013HNZY06)
河南中医药大学特色学科建设项目(No.16HNZYYDXTS03)
关键词
前列安/治疗作用
前列腺增生逼尿肌受损/中医药疗法
临床观察
Qianliean/therapeutic action
Prostatic hyperplasia detrusorunderactivity/TCM therapy
Clinical observation
